CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase
- PMID: 24469069
- DOI: 10.1007/s10456-014-9417-6
CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase
Abstract
CXC chemokines influence a variety of biological processes, such as angiogenesis, both in a physiological and pathological context. Platelet factor-4 (PF-4)/CXCL4 and its variant PF-4var/CXCL4L1 are known to favor angiostasis by inhibiting endothelial cell proliferation and chemotaxis. CXCL4L1 in particular is a potent inhibitor of angiogenesis with anti-tumoral characteristics, both through regulation of neovascularization and through attraction of activated lymphocytes. However, its underlying signaling pathways remain to be elucidated. Here, we have identified various intracellular pathways activated by CXCL4L1 in comparison with other CXCR3 ligands, including CXCL4 and interferon-γ-induced protein 10/CXCL10. Signaling experiments show involvement of the mitogen-activated protein kinase (MAPK) family in CXCR3A-transfected cells, activated lymphocytes and human microvascular endothelial cells (HMVEC). In CXCR3A transfectants, CXCL4 and CXCL4L1 activated p38 MAPK, as well as Src kinase within 30 and 5 min, respectively. Extracellular signal-regulated kinase (ERK) phosphorylation occurred in activated lymphocytes, yet was inhibited in microvascular and lymphatic endothelial cells. CXCL4L1 and CXCL4 counterbalanced the angiogenic chemokine stromal cell-derived factor-1/CXCL12 in both endothelial cell types. Notably, inhibition of ERK signaling by CXCL4L1 and CXCL4 in lymphatic endothelial cells implies that these chemokines might also regulate lymphangiogenesis. Furthermore, CXCL4, CXCL4L1 and CXCL10 slightly enhanced forskolin-stimulated cAMP production in HMVEC. Finally, CXCL4, but not CXCL4L1, induced activation of p70S6 kinase within 5 min in HMVEC. Our findings confirm that the angiostatic chemokines CXCL4L1 and CXCL4 activate both CXCR3A and CXCR3B and bring new insights into the complexity of their signaling cascades.
Similar articles
-
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.Blood. 2011 Jan 13;117(2):480-8. doi: 10.1182/blood-2009-11-253591. Epub 2010 Oct 27. Blood. 2011. PMID: 20980681 Free PMC article.
-
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.Cancer Res. 2007 Jun 15;67(12):5940-8. doi: 10.1158/0008-5472.CAN-06-4682. Cancer Res. 2007. PMID: 17575164
-
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B.Int J Biochem Cell Biol. 2008;40(9):1764-74. doi: 10.1016/j.biocel.2008.01.008. Epub 2008 Jan 16. Int J Biochem Cell Biol. 2008. PMID: 18291705
-
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.Cytokine Growth Factor Rev. 2011 Feb;22(1):1-18. doi: 10.1016/j.cytogfr.2010.10.011. Epub 2010 Nov 26. Cytokine Growth Factor Rev. 2011. PMID: 21111666 Review.
-
CXCR3 ligands in disease and therapy.Cytokine Growth Factor Rev. 2015 Jun;26(3):311-27. doi: 10.1016/j.cytogfr.2014.11.009. Epub 2014 Nov 22. Cytokine Growth Factor Rev. 2015. PMID: 25498524 Review.
Cited by
-
Lymph Vessels Associate with Cancer Stem Cells from Initiation to Malignant Stages of Squamous Cell Carcinoma.Int J Mol Sci. 2023 Sep 2;24(17):13615. doi: 10.3390/ijms241713615. Int J Mol Sci. 2023. PMID: 37686421 Free PMC article.
-
Heterodimers Are an Integral Component of Chemokine Signaling Repertoire.Int J Mol Sci. 2023 Jul 19;24(14):11639. doi: 10.3390/ijms241411639. Int J Mol Sci. 2023. PMID: 37511398 Free PMC article. Review.
-
Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide.Clin Transl Immunology. 2022 Feb 2;11(2):e1370. doi: 10.1002/cti2.1370. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35140938 Free PMC article.
-
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.Oncotarget. 2014 Nov 15;5(21):10916-33. doi: 10.18632/oncotarget.2538. Oncotarget. 2014. PMID: 25373734 Free PMC article.
-
A multi-targeted approach to suppress tumor-promoting inflammation.Semin Cancer Biol. 2015 Dec;35 Suppl:S151-S184. doi: 10.1016/j.semcancer.2015.03.006. Epub 2015 May 5. Semin Cancer Biol. 2015. PMID: 25951989 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous